Literature DB >> 17371249

Regulation of class IA PI3Ks.

H Wu1, Y Yan, J M Backer.   

Abstract

Class IA PI3Ks (phosphoinositide 3-kinases) regulate a wide range of cellular responses through the production of PI(3,4,5)P(3) (phosphatidylinositol 3,4,5-trisphosphate) in cellular membranes. They are activated by receptor tyrosine kinases, by Ras and Rho family GTPases, and in some cases by G(betagamma) subunits from trimeric G-proteins. Crystallographic studies on the related class IB PI3Kgamma, and biochemical and structural studies on the class IA PI3Ks, have led to new insights into how these critical enzymes are regulated in normal cells and how mutations can lead to their constitutive activation in transformed cells. The present paper will discuss recent studies on the regulation of class I (p85/p110) PI3Ks, with a focus on the role of SH2 domains (Src homology 2 domains) in the p85 regulatory subunit in modulating PI3K activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371249     DOI: 10.1042/BST0350242

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.

Authors:  Hashem A Dbouk; Huan Pang; Andras Fiser; Jonathan M Backer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-28       Impact factor: 11.205

Review 2.  Class I PI3K in oncogenic cellular transformation.

Authors:  L Zhao; P K Vogt
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

3.  Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.

Authors:  Haiyan Wu; S Chandra Shekar; Rory J Flinn; Mirvat El-Sibai; Bijay S Jaiswal; K Ilker Sen; Vasantharajan Janakiraman; Somasekar Seshagiri; Gary J Gerfen; Mark E Girvin; Jonathan M Backer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

4.  p87 and p101 subunits are distinct regulators determining class IB phosphoinositide 3-kinase (PI3K) specificity.

Authors:  Aliaksei Shymanets; Kirsten Bucher; Sandra Beer-Hammer; Christian Harteneck; Bernd Nürnberg
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

5.  Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion.

Authors:  Natalia G Sampaio; Wenfeng Yu; Dianne Cox; Jeffrey Wyckoff; John Condeelis; E Richard Stanley; Fiona J Pixley
Journal:  J Cell Sci       Date:  2011-05-24       Impact factor: 5.285

6.  PI3King the right partner: unique interactions and signaling by p110β.

Authors:  Hashem A Dbouk
Journal:  Postdoc J       Date:  2015-06

Review 7.  The regulation of class IA PI 3-kinases by inter-subunit interactions.

Authors:  Jonathan M Backer
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure-based drug design.

Authors:  Ping Chen; Ya-Li Deng; Simon Bergqvist; Matthew D Falk; Wei Liu; Sergei Timofeevski; Alexei Brooun
Journal:  Protein Sci       Date:  2014-08-07       Impact factor: 6.725

9.  The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase.

Authors:  Angela F Messmer-Blust; Sujata Balasubramanian; Victoria Y Gorbacheva; Jonathan A Jeyaratnam; Deborah J Vestal
Journal:  Mol Biol Cell       Date:  2010-05-26       Impact factor: 4.138

10.  Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity.

Authors:  Kellie A Mouchemore; Natalia G Sampaio; Michael W Murrey; E Richard Stanley; Brian J Lannutti; Fiona J Pixley
Journal:  FEBS J       Date:  2013-06-05       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.